Y Intercept (Hong Kong) LTD Celldex Therapeutics, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.83 Billion
- Q3 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 48,906 shares of CLDX stock, worth $1.27 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
48,906
Previous 58,398
16.25%
Holding current value
$1.27 Million
Previous $1.19 Million
6.48%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding CLDX
# of Institutions
202Shares Held
68.3MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$159 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$136 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$103 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$99.3 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.22B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...